Fig. 4From: Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysisSensitivity analysis in this mate-analysis. a sensitivity analysis for overall survival; b sensitivity analysis for progression-free survivalBack to article page
